Xenon Pharmaceuticals XENE
NASDAQ XENE
$38.02 -0.91 (-2.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Other Accumulated Expenses (2013 - 2025)

Updated

Xenon Pharmaceuticals (XENE) reported Other Accumulated Expenses of $966,000 for Q4 2025, up 35.3% from $714,000 a year earlier and up 3.3% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Other Accumulated Expenses (2013 - 2025) Analysis & Trends

Dating back to Q4 2013, Xenon Pharmaceuticals' Other Accumulated Expenses record includes 46 quarters.

  • Other Accumulated Expenses has a five-year compound annual growth rate of 69.5% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $714,000 in FY2024, $341,000 in FY2022 (+189.0%) and $118,000 in FY2021 (+71.0%).
  • The Q4 2025 figure ranks as the highest quarterly Other Accumulated Expenses since Q3 2024.
  • Year over year, Other Accumulated Expenses gained in three of the last six quarters, with growth averaging 184.9%.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q3 2024 (growth of 909.3%); the low point was Q1 2024 (a decline of 86.1%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $935,000 (Q3 2025), $439,000 (Q2 2025) and $450,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xenon Pharmaceuticals 3.68 Bn 3.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 966,000.00
Sep 30, 2025 935,000.00
Jun 30, 2025 439,000.00
Mar 31, 2025 450,000.00
Dec 31, 2024 714,000.00
Sep 30, 2024 1.08 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 106,000.00
Sep 30, 2023 107,000.00
Jun 30, 2023 91,000.00
Mar 31, 2023 764,000.00
Dec 31, 2022 341,000.00
Sep 30, 2022 45,000.00
Jun 30, 2022 240,000.00
Mar 31, 2022 282,000.00
Dec 31, 2021 118,000.00
Sep 30, 2021 26,000.00
Jun 30, 2021 74,000.00
Mar 31, 2021 82,000.00
Dec 31, 2020 69,000.00
API Access

Xenon Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=XENE&period=max&api_key=YOUR_API_KEY